Project Details
Description
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of SARS-CoV-2 Variant (BA.4 /5) mRNA Vaccine (ABO1020) in Healthy Subjects Aged 18 Years and Older Who Have Completed the Full Vaccination
| Status | Finished |
|---|---|
| Effective start/end date | 23/11/22 → 31/07/24 |
Collaborative partners
- Burjeel Hospital
- life care hospital
- Medeor Hospital
- Suzhou Abogen Biosciences Co., Ltd. (lead)
- Abu Dhabi Health Services Company
- Burjeel Medical City
Keywords
- COVID-19
- Omicron
- Pneumonia, Viral
- Pneumonia
- Respiratory Tract Infections
- Infections
- Virus Diseases
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Lung Diseases
- Respiratory Tract Diseases
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.